Lidocain/Mesocain

Lidocain/Mesocain

Mechanism of action

  • Antiarrhythmic (Class Ib); Amide-type local anaesthetic
  • As an antiarrhythmic: suppresses diastolic depolarization and spontaneous creation of current in the ventricles while having no effect on the AV node and atria. 
  • As an anaesthetic: blocks sodium channels on nerve cells which stabilizes its membranes and prevents depolarization, which means that action potential is not transmitted. 

Indications and dose

Pharmacokinetics

Onset of action: 45-90 seconds

Half-life of elimination: 1.5–2 hours

Metabolism: Hepatic 

Elimination: Kidneys 

Directions for administration

It’s recommended to lower the dose by 40 % in patients with heart failure or hepatic impairment.

Potassium levels should be checked before administration because hypokalaemia reduces the effect of lidocaine.

Medicinal forms

Solution of injection/infusion (5 mg/ml, 10 mg/ml, 20 mg/ml)

  • 1 vial = 2 ml (10 mg, 20 mg, 40 mg)

Side-effects

Malignant hyperthermia

Bradycardia

Arrhythmias 

Heart conduction disorders

Nausea, vomiting

Confusion

References

  1. Xylocaine, Zingo (lidocaine anesthetic) dosing, indications, interactions, adverse effects, and more (medscape.com)
  2. LIDOCAINE EGIS, 20MG/ML INJ SOL 10X2ML, State Institute for Drug Control (sukl.eu)
  3. Lidocaine: Uses, Interactions, Mechanism of Action | DrugBank Online